Lotrich, Francis E <br/><br/>
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.  [electronic resource] 

 -  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research  Mar 2011 
 - 331-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-7465 
<br/><br/><label>Standard No.: </label>10.1089/jir.2010.0074  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Female<br/>Genotype<br/>Hepacivirus<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Interferons<br/>Interleukins--genetics<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide